Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs34062664 | chr2:24356168 | CT/C | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs34076068 | chr14:74516497 | G/A | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs34078951 | chr14:74553372 | GA/G | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |
PCPG | rs34088324 | chr14:74339338 | C/T | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs34088942 | chr17:50299568 | C/CT | 6.23E-5 | 177 | 25.53 | 28.38 | 14.47 | KM Plot |
PCPG | rs34093108 | chr12:26881788 | C/T | 8.77E-5 | 178 | 24.3 | 28.47 | 5.97 | KM Plot |
PCPG | rs34099549 | chr12:124085062 | G/A | 4.04E-5 | 177 | 25.87 | 19.87 | 20.13 | KM Plot |
PCPG | rs34101533 | chr2:107228445 | AC/A | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs34111839 | chr12:56676817 | CT/C | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs34121364 | chr14:74402006 | A/G | 1.03E-5 | 177 | 25.4 | 28.38 | 10.43 | KM Plot |
PCPG | rs34127605 | chr17:50293499 | T/C | 3.32E-5 | 178 | 27.27 | 25.97 | 14.43 | KM Plot |
PCPG | rs34127884 | chr14:74386824 | T/G | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs34133467 | chr10:29853582 | CCA/C | 5.6E-11 | 176 | 25.67 | 17.52 | 10.3 | KM Plot |
PCPG | rs34137148 | chr2:24334731 | C/CA | 0.000129 | 175 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs34137719 | chr16:89587118 | GT/G | 0.000342 | 171 | 25.92 | 25.53 | 19.3 | KM Plot |